Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Colorado, Nebraska

Key briefs were filed in Colorado and Nebraska in ongoing state 340B contract pharmacy litigation.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Senators Abruptly Pull 340B Bill from Hearing; Massachusetts Lawmakers Debate Drug Pricing Measures

California lawmakers cancelled a hearing on a 340B contract pharmacy bill on July 16, while Massachusetts lawmakers debated multiple 340B provisions on July 15.
California state senators yesterday abruptly pulled a 340B contract pharmacy access bill from a scheduled hearing just days before a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Appeals 340B Rebate Ruling, Hospitals Laud Federal Judge’s Rejection of Drugmaker Lawsuit

Johnson & Johnson is appealing a Washington, D.C. federal district judge's ruling on the drugmaker's 340B rebate proposal.
Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Urge Appeals Court to Toss Hospital Group’s Cross-Appeal in 340B Rebate Case

Three drugmakers recently asked a federal appeals court in Washington, D.C. to dismiss 340B Health's cross-appeal filed as part of ongoing 340B rebate litigation.
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers, Hospital Group Appeal Dueling Aspects of 340B Rebate Ruling

Multiple drugmakers and an intervening hospital trade group are appealing different aspects of a federal district judge's ruling on 340B rebates.
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Appellate Court Fast-Tracks Drugmakers’ Appeal of 340B Rebate Ruling

A federal appellate court in Washington, D.C. will hear two drugmakers' appeal of a lower courts 340B rebate ruling on an expedited schedule.
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live